Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Suspected sepsis: recognition, diagnosis and early management

NICE guideline
Reference number: NG51
Published: 13 July 2016
Last updated: 19 March 2024

History

Additional documents published

Statement Roadmap (PDF 283 KB)

Published:

06 March 2024

Consultation comments published

Consultation comments and responses 1st Consultation (PDF 1.21 MB)

Published:

31 January 2024
Consultation comments and responses 2nd Consultation (PDF 1.25 MB)

Published:

31 January 2024

Equality and health inequalities assessment

Equality and health inequalities assessment (PDF version) (PDF 375 KB)

Published:

08 February 2024

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 626 KB)

Published:

08 November 2023
Evidence review C (PDF 1.76 MB)

Published:

08 November 2023
Supporting documentation Algorithms (PDF 240 KB)

Published:

08 November 2023
Comments form (MSWord 51 KB)

Published:

09 November 2023

Committee list updated

Committee member list (PDF 130 KB)

Published:

31 January 2024

Declaration of interests

Register of interests (PDF 483 KB)

Published:

31 January 2024

Stakeholder list updated

Stakeholder list (PDF 160 KB)

Published:

31 January 2024

Draft guidance consultation

Draft guidance consultation
Supporting documentation Table 1 – Amendments to NG51 – Consultation draft (PDF 670 KB)

Published:

24 March 2023
Draft guideline (PDF 601 KB)

Published:

24 March 2023
Evidence review A (PDF 1.46 MB)

Published:

24 March 2023
Evidence review B (PDF 1.48 MB)

Published:

24 March 2023
Supporting documentation Scope (PDF 221 KB)

Published:

24 March 2023
Committee member list (PDF 126 KB)

Published:

24 March 2023
Committee member list DOI (PDF 330 KB)

Published:

24 March 2023
Comments form (MSWord 42 KB)

Published:

24 March 2023

Pre-consultation documents released

Review questions (PDF 147 KB)

Published:

09 February 2023

Committee meetings

Committee meeting
Minutes 1 (PDF 201 KB)

Published:

09 August 2022
Minutes 2 (PDF 197 KB)

Published:

13 September 2022
Minutes 3 (PDF 231 KB)

Published:

11 November 2022
Minutes 4 (PDF 203 KB)

Published:

10 January 2023
Minutes 1a (PDF 175 KB)

Published:

13 July 2023
Minutes 2a (PDF 200 KB)

Published:

08 August 2023
Minutes 5 (PDF 172 KB)

Published:

11 December 2023

Scope published

Final scope revised January 2024 (PDF 220 KB)

Published:

06 March 2024
Final scope (PDF 221 KB)

Published:

22 September 2022

Original development on 13 July 2016

Consultation comments published
Consultation comments and responses (PDF 1.46 MB)

Published:

13 July 2016
Equality and health inequalities assessment
Equality impact assessment (PDF 271 KB)

Published:

13 July 2016
Committee list updated
Committee member list (PDF 262 KB)

Published:

14 July 2016
Draft guidance consultation
Draft guidance consultation
Draft guideline (PDF 5.76 MB)

Published:

11 January 2016
Comments form (MSWord 38 KB)

Published:

11 January 2016
Short version of draft guideline (PDF 901 KB)

Published:

11 January 2016
Guideline appendix A - G (PDF 2 MB)

Published:

11 January 2016
Guideline appendix H (PDF 3.85 MB)

Published:

11 January 2016
Guideline appendix I - O (PDF 2.37 MB)

Published:

11 January 2016
Equality impact assessment Section 3 (PDF 202 KB)

Published:

13 April 2016
Equality impact assessment Section 4 (PDF 200 KB)

Published:

03 May 2016
Stakeholder list updated
Stakeholder list (PDF 42 KB)

Published:

08 January 2016
Pre-consultation documents released
Economic plan (MSWord 32 KB)

Published:

25 November 2015
Review questions (MSWord 15 KB)

Published:

25 November 2015
Search strategies (MSWord 184 KB)

Published:

25 November 2015
Committee meeting
Minutes 9 (PDF 102 KB)

Published:

12 December 2016
Minutes 10 (PDF 99 KB)

Published:

12 December 2016
Minutes 11 (PDF 112 KB)

Published:

12 December 2016
Minutes 12 (PDF 96 KB)

Published:

12 December 2016
The recognition, diagnosis and management of severe : scope comments table
The recognition, diagnosis and management of severe : scope comments table (PDF 467 KB)

Published:

03 November 2014
The recognition, diagnosis and management of severe : guideline development and consultation
The recognition, diagnosis and management of severe : guideline development and consultation
The recognition, diagnosis and management of severe : guideline development group minutes
The recognition, diagnosis and management of severe : GDG8 minutes 29 April 2015 (PDF 94 KB)

Published:

13 July 2015
The recognition, diagnosis and management of severe : GDG7 minutes 28 April 2015 (PDF 266 KB)

Published:

13 July 2015
The recognition, diagnosis and management of severe : GDG6 minutes 4 March 2015 (PDF 271 KB)

Published:

13 July 2015
The recognition, diagnosis and management of severe : GDG5 minutes 16 January 2015 (PDF 105 KB)

Published:

13 July 2015
The recognition, diagnosis and management of severe : GDG4 minutes 2 December 2014 (PDF 108 KB)

Published:

06 February 2015
The recognition, diagnosis and management of severe : GDG3 minutes 21 October 2014 (PDF 109 KB)

Published:

06 February 2015
The recognition, diagnosis and management of severe : GDG2 minutes 5 September 2014 (PDF 95 KB)

Published:

06 February 2015
The recognition, diagnosis and management of severe : GDG1 minutes 11 July 2014 (PDF 113 KB)

Published:

06 February 2015
The recognition, diagnosis and management of severe : GDG members list (PDF 103 KB)

Published:

05 September 2014
The recognition, diagnosis and management of severe : scope consultation
The recognition, diagnosis and management of severe : scope consultation information
The recognition, diagnosis and management of severe : equality impact assessment form - scoping (PDF 222 KB)

Published:

20 July 2015
The recognition, diagnosis and management of severe : final scope (PDF 211 KB)

Published:

24 September 2014
The recognition, diagnosis and management of severe : draft scope (PDF 188 KB)

Published:

04 April 2014
Stakeholder list
Stakeholder list (PDF 14 KB)

Published:

25 April 2014